Recce Pharmaceuticals Ltd:675 万澳元研发回扣已获批准
Recce Pharmaceuticals Ltd:向股东提交的年度报告
Recce Pharmaceuticals Ltd:初步最终报告
Recce Pharmicals Ltd:附录4D和中期财务报告
Recce Pharmaceuticals Ltd:向股东提交的年度报告
Recce Pharmaceuticals Ltd:附录 4E 和未经审计的初步报告
Recce Pharmaceuticals Ltd:附录4D和中期财务报告
Recce Pharmaceuticals Ltd:提交给股东的年度报告
Recce Pharmaceuticals Ltd:附录4E
Recce Pharmaceuticals Ltd:附录4D和中期财务报告
Recce Pharmaceuticals Ltd:提交给股东的年度报告
Recce Pharmaceuticals Ltd:附录4E
Recce Pharmaceuticals Ltd:附录4D和半年报告
Recce Pharmaceuticals Ltd:2020年度报告
Recce Pharmaceuticals Ltd:附录4E
Recce Pharmaceuticals Ltd:半年报及帐目
Recce Pharmaceuticals Ltd:2019年年报
Recce Pharmaceuticals Ltd:附录4E--初步最终报告
Recce Pharmaceuticals Ltd:半年报及帐目
Recce Pharmaceuticals Ltd:2018年年报